Trulicity Trulicity, another diabetes drug developed by Eli Lilly, is also named in lawsuits that highlight the risks of gastrointestinal injuries, abdominal pain, nausea, and drug-induced pancreatitis
For individuals with type 2 diabetes, low blood sugar levels (hypoglycemia) can be a concern when GLP-1 agonists are used in combination with other glucose-lowering medications, such as sulfonylureas or insulin
Retrieved 6 January 2020
And then when you do eat, you are so hungry that you eat too much, too fast, triggering severe nausea and GI distress
These medications have a low risk of causing low blood sugar when used alone but may increase this risk when combined with insulin or sulfonylureas
How is BAC water volume calculated for reconstituting a 5 mg retatrutide vial